CA Patent

CA3237758A1 — Use of maribavir for the treatment of and treatment regimens thereof

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2023-05-25 · 3y expired

What this patent protects

Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.

USPTO Abstract

Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.

Drugs covered by this patent

Patent Metadata

Patent number
CA3237758A1
Jurisdiction
CA
Classification
—
Expires
2023-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.